Wockhardt Widens Miqnaf Access as Q2 Revenue Rises 24%
Wockhardt Miqnaf access widens after DCGI lifted a supply condition on the novel antibiotic, as Q2 FY27 revenue rose 24% to ₹969 crore on biotech growth.
DCGI
CDSCO Asks States to Enforce Batch Testing of Raw Materials, Excipients and Finished Drugs
In a 27 October notice, DCGI Rajeev Raghuvanshi has asked state and UT drug regulators to make manufacturers test every batch of raw materials, critical excipients such as propylene glycol, glycerol and sorbitol, and finished products, and to enforce vendor qualification after inspections found lapses.
Supreme Court Raps Centre, DCGI Over Antifungal Drug Sold for Five Years on Expired Covid-Era Approvals
The Supreme Court questioned why regulators took five years to act against companies allegedly selling Liposomal Amphotericin B under lapsed Covid-era emergency permissions, and said its directions will apply across the board.
Akums Launches DCGI-Approved Lasmiditan Dispersible Tablets for Acute Migraine
Akums Drugs & Pharmaceuticals Ltd. has announced the launch of Lasmiditan dispersible tablets, approved by the DCGI, for the acute […]
MSD’s Keytruda receives DCGI approval for treating triple-negative breast cancer and renal cell carcinoma
Merck, known as MSD outside the U.S. and Canada, has recently earned the endorsement of the Drug Controller General of […]
DCGI permits Serum Institute to export malaria vaccine
India’s drug controller has permitted the export of the first produced-in-India vaccine against malaria, produced by scientists at the University […]
DCGI Gives Nod to Cipla to Import Moderna’s Covid-19 Vaccine for Emergency Use Authorisation
Mumbai-headquartered pharma major Cipla has got a nod from The Drugs Controller General of India (DCGI) on Tuesday for importing […]
CSIR, Laxai Life Sciences Receives Regulatory Approval for Colchicine Clinical Trials on Covid-19 Patients
Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt Ltd Hyderabad has been given the regulatory approval […]
Optimus Pharma Gets DCGI Nod for Conducting Phase-III Clinical Trials for Molnupiravir on Mild-to-Moderate Covid Patients
Optimus Pharma on Wednesday received DCGI nod for conducting phase-III clinical trials for orally-administered Molnupiravir capsules on patients with mild-to-moderate […]
Over 1.1 Cr Indians Vaccinated So far
At least 1,10,85,173 beneficiaries have been vaccinated for Covid-19 through 2,30,888 sessions in the country, according to a provisional report […]
DCGI okays phase-1 human trials of ‘antisera’ with potential to treat COVID-19
The DGCI (Drugs Controller General of India), the apex healthcare research body has given approval for conducting Phase-1 human clinical […]
Serum-Oxford covid-19 vaccine gets DCGI nod for phase 2, 3 trials in India
The Serum Institute of India (SII) has received approval from Drug Controller General of India (DCGI) to move ahead for […]
Mylan gets DCGI approval for anti-TB drug Pretomanid
Mylan, a global pharmaceutical company, today announced that the Drug Controller General of India (DCGI) has approved the anti-tuberculosis drug […]
